Canalicular stenosis secondary to docetaxel (Taxotere): a newly recognized side effectESMAELI, Bita; VALERO, Vicente; AHMADI, M. Amir et al.Ophthalmology (Rochester, MN). 2001, Vol 108, Num 5, pp 994-995, issn 0161-6420Article

Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancerESMAELI, Bita; HORTOBAGYI, Gabriel N; ESTEVA, Francisco J et al.Ophthalmology (Rochester, MN). 2002, Vol 109, Num 6, pp 1188-1191, issn 0161-6420Article

Paclitaxel in the multimodality treatment for inflammatory breast carcinomaCRISTOFANILLI, Massimo; BUZDAR, Aman U; UENO, Naoto et al.Cancer. 2001, Vol 92, Num 7, pp 1775-1782, issn 0008-543XArticle

Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by ImmunohistochemistryIWAMOTO, Takayuki; BOOSER, Daniel; MATSUOKA, Junji et al.Journal of clinical oncology. 2012, Vol 30, Num 7, pp 729-734, issn 0732-183X, 6 p.Article

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancerHESS, Kenneth R; ANDERSON, Keith; ROUZIER, Roman et al.Journal of clinical oncology. 2006, Vol 24, Num 26, pp 4236-4244, issn 0732-183X, 9 p.Article

Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancerESTEVA, Francisco J; VALERO, Vicente; SNEIGE, Nour et al.Journal of clinical oncology. 2002, Vol 20, Num 7, pp 1800-1808, issn 0732-183XArticle

Effect of Adjuvant/Neoadjuvant Trastuzumab on Clinical Outcomes in Patients With HER2-Positive Metastatic Breast CancerMURTHY, Rashmi K; VARMA, Ankur; BOOSER, Daniel et al.Cancer. 2014, Vol 120, Num 13, pp 1932-1938, issn 0008-543X, 7 p.Article

Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancerDEAN-COLOMB, Windy; HESS, Kenneth R; HORTOBAGYI, Gabriel N et al.Breast cancer research and treatment. 2013, Vol 137, Num 2, pp 631-636, issn 0167-6806, 6 p.Article

A Phase 1 Study of Weekly Everolimus (RAD001) in Combination With Docetaxel in Patients With Metastatic Breast CancerMOULDER, Stacy; GLADISH, Gregory; RIVERA, Edgardo et al.Cancer. 2012, Vol 118, Num 9, pp 2378-2384, issn 0008-543X, 7 p.Article

Phase II trial of 10-EDAM in the treatment of metastatic breast cancerBEINART, Garth A; GONZALEZ-ANGULO, Ana M; YOUNG, James A et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 1, pp 61-67, issn 0344-5704, 7 p.Article

Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast CancerIWAMOTO, Takayuki; BIANCHINI, Giampaolo; HOLMES, Frankie A et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 3, pp 264-272, issn 0027-8874, 9 p.Article

Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinomaPUSZTAI, Lajos; WAGNER, Peter; ROUZIER, Roman et al.Cancer. 2005, Vol 104, Num 4, pp 682-691, issn 0008-543X, 10 p.Article

Gene Expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumorsPUSZTAI, Lajos; AYERS, Mark; ARUN, Banu et al.Clinical cancer research. 2003, Vol 9, Num 7, pp 2406-2415, issn 1078-0432, 10 p.Article

Phase I study of a third-generation selective estrogen receptor modulator, LY353381.HCl, in metastatic breast cancerMÜNSTER, Pamela N; BUZDAR, Aman; NORTON, Larry et al.Journal of clinical oncology. 2001, Vol 19, Num 7, pp 2002-2009, issn 0732-183XArticle

Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancerRIVERA, Edgardo; VALERO, Vicente; HORTOBAGYI, Gabriel N et al.Journal of clinical oncology. 2001, Vol 19, Num 6, pp 1716-1722, issn 0732-183XArticle

Women age ≤ 35 years with primary breast carcinoma : Disease features at presentationGONZALEZ-ANGULO, Ana M; BROGLIO, Kristine; ARUN, Banu et al.Cancer. 2005, Vol 103, Num 12, pp 2466-2472, issn 0008-543X, 7 p.Conference Paper

A phase I and pharmacokinetic study of TAS-108 in postmenopausal female patients with locally advanced, locally recurrent inoperable, or progressive metastatic breast cancerBLAKELY, L. Johnetta; BUZDAR, Aman; CHANG, Hsiu-Yin et al.Clinical cancer research. 2004, Vol 10, Num 16, pp 5425-5431, issn 1078-0432, 7 p.Article

A phase III trial of sequential adjuvant chemotherapy for operable breast carcinoma: Final analysis with 10-year follow-upASSIKIS, Vasily; BUZDAR, Aman; HORTOBAGYI, Gabriel et al.Cancer. 2003, Vol 97, Num 11, pp 2716-2723, issn 0008-543X, 8 p.Article

Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancerPUSZTAI, Lajos; JIM HOU ZHEN; BOOSER, Daniel et al.Journal of clinical oncology. 2003, Vol 21, Num 18, pp 3454-3461, issn 0732-183X, 8 p.Article

Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapyRIVERA, Edgardo; HOLMES, Frankie A; HORTOBAGYI, Gabriel N et al.Cancer. 2000, Vol 89, Num 11, pp 2195-2201, issn 0008-543XArticle

Lack of activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancerRIVERA, Edgardo; VALERO, Vicente; ESTEVA, Francisco J et al.Cancer chemotherapy and pharmacology. 2002, Vol 49, Num 4, pp 299-302, issn 0344-5704Article

Phase I study of eniluracil and oral 5-fluorouracil in combination with docetaxel in the treatment of patients with metastatic breast carcinomaRIVERA, Edgardo; VALERO, Vicente; CRISTOFANILLI, Massimo et al.Cancer. 2002, Vol 94, Num 9, pp 2321-2326, issn 0008-543XArticle

A Phase 2 Study of A Fixed Combination of Uracil and Ftorafur (UFT) and Leucovorin Given Orally in A 3-times-daily Regimen to Treat Patients With Recurrent Metastatic Breast CancerHORTOBAGYI, Gabriel N; HEIM, William; HUTCHINS, Laura et al.Cancer. 2010, Vol 116, Num 6, pp 1440-1445, issn 0008-543X, 6 p.Article

Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancerBOOSER, Daniel J; ESTEVA, Francisco J; RIVERA, Edgardo et al.Cancer chemotherapy and pharmacology. 2002, Vol 50, Num 1, pp 6-8, issn 0344-5704, 3 p.Article

A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancersTRENT, Jonathan C; VALERO, Vicente; CRISTOFANILLI, Massimo et al.Clinical cancer research. 2003, Vol 9, Num 7, pp 2426-2434, issn 1078-0432, 9 p.Article